This SPA was submitted to provide routine coverage of routine patient cost associated with participation in qualifying clinical trials and to comply with Div. CC, Title II, Section 210 of the Consolidated Appropriations Act, 2021 (P.L.116-260).
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media